Cargando…
Towards Reduction or Substitution of Cytotoxic DMSO in Biobanking of Functional Bioengineered Megakaryocytes
Donor platelet transfusion is currently the only efficient treatment of life-threatening thrombocytopenia, but it is highly challenged by immunological, quality, and contamination issues, as well as short shelf life of the donor material. Ex vivo produced megakaryocytes and platelets represent a pro...
Autores principales: | Pogozhykh, Denys, Eicke, Dorothee, Gryshkov, Oleksandr, Wolkers, Willem F., Schulze, Kai, Guzmán, Carlos A., Blasczyk, Rainer, Figueiredo, Constança |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7589913/ https://www.ncbi.nlm.nih.gov/pubmed/33081128 http://dx.doi.org/10.3390/ijms21207654 |
Ejemplares similares
-
Characterization of induced pluripotent stem cell‐derived megakaryocyte lysates for potential regenerative applications
por: Baigger, Anja, et al.
Publicado: (2018) -
Large-scale production of megakaryocytes in microcarrier-supported stirred suspension bioreactors
por: Eicke, Dorothee, et al.
Publicado: (2018) -
Repeated Freezing Procedures Preserve Structural and Functional Properties of Amniotic Membrane for Application in Ophthalmology
por: Pogozhykh, Olena, et al.
Publicado: (2020) -
Generation of HLA Universal Megakaryocytes and Platelets by Genetic Engineering
por: Figueiredo, Constanca, et al.
Publicado: (2021) -
Encapsulating Non-Human Primate Multipotent Stromal Cells in Alginate via High Voltage for Cell-Based Therapies and Cryopreservation
por: Gryshkov, Oleksandr, et al.
Publicado: (2014)